Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Ge Healthcare Technologies Inc. Revenue & Financial Statements
Ge Healthcare Technologies Inc. reported revenue of $20.6B for the fiscal year ended December 31, 2025, up 4.8% year over year, with net income of $2.2B and diluted EPS of $4.55.
- Company
- Ge Healthcare Technologies Inc. GEHC · NASDAQ
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 3 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | 19.6B | 19.7B | 20.6B |
| Cost of revenue | — | — | — |
| Gross profit | 7.9B | 8.2B | 8.2B |
| Operating income | 2.4B | 2.6B | 2.8B |
| Pretax income | 1.5B | 2.0B | 1.7B |
| Net income | 755.0M | 1.3B | 2.2B |
| Diluted EPS | 3.03 | 4.34 | 4.55 |
| EBITDA | 2.7B | 2.9B | 3.0B |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.7B | 4.8B | 4.9B | 5.3B | 4.8B | 5.0B | 5.1B | 5.7B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | 1.9B | 2.0B | 2.0B | 2.3B | 2.0B | 2.0B | 2.0B | 2.3B |
| Operating income | 540.0M | 608.0M | 676.0M | 801.0M | 629.0M | 654.0M | 653.0M | 827.0M |
| Pretax income | 512.0M | 578.0M | 658.0M | 834.0M | 692.0M | 613.0M | 643.0M | 821.0M |
| Net income | 278.0M | 370.0M | 544.0M | 114.0M | 744.0M | 594.0M | 380.0M | 602.0M |
| Diluted EPS | 0.81 | 0.93 | 1.02 | 1.57 | 1.23 | 1.06 | 0.98 | 1.29 |
| EBITDA | 608.0M | — | 742.0M | 866.0M | 695.0M | — | 728.0M | 901.0M |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total assets | 32.5B | 33.1B | 36.9B |
| Current assets | 9.4B | 9.9B | 12.5B |
| Cash & equivalents | 2.5B | 2.9B | 4.5B |
| Total liabilities | 25.1B | 24.4B | 26.3B |
| Current liabilities | 9.0B | 9.6B | 9.1B |
| Long-term debt | 8.4B | 7.4B | 9.5B |
| Total debt | 9.4B | 9.0B | 10.0B |
| Stockholders’ equity | 7.1B | 8.4B | 10.4B |
| Net debt | 6.9B | 6.1B | 5.5B |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | — | — | — |
| Investing cash flow | (558.0M) | (914.0M) | (1.0B) |
| Financing cash flow | (478.0M) | (573.0M) | 617.0M |
| Capital expenditure | — | — | — |
| Free cash flow | — | — | — |
| Dividends paid | 41.0M | 55.0M | 64.0M |
| Stock-based compensation | 114.0M | 125.0M | 130.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every GEHC filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.